Antimicrobial peptides inhibit polyinosinic-polycytidylic acid-induced immune responses

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 5653-5659

  Hasan, Maroof ^a   Ruksznis, Catarina ^a   Wang, Yan ^b   Leifer, Cynthia Anne ^a  

^a Department of Obstetrics Gynecology   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; POLYINOSINIC POLYCYTIDYLIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 3;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG PROTEIN BINDING; IMMUNOMODULATION; IMMUNOREGULATION; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CATHELICIDINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; MICE; MICE, INBRED C57BL; POLY I-C; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 82755186759     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102144     Document Type: Article

References (40)

1. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680. (Pubitemid 32747155)
2. O'Neill, L. A., K. A. Fitzgerald, and A. G. Bowie. 2003. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24: 286-290.
3. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376. (Pubitemid 37174535)
4. Chockalingam, A., J. C. Brooks, J. L. Cameron, L. K. Blum, and C. A. Leifer. 2009. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol. Cell Biol. 87: 209-217.
5. Kim, Y. M., M. M. Brinkmann, M. E. Paquet, and H. L. Ploegh. 2008. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452: 234-238.
6. Latz, E., A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik, and D. T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5: 190-198. (Pubitemid 38208361)
7. Leifer, C. A., J. C. Brooks, K. Hoelzer, J. L. Lopez, M. N. Kennedy, A. Mazzoni, and D. M. Segal. 2006. Cytoplasmic targeting motifs control localization of Toll-like receptor 9. J. Biol. Chem. 281: 35585-35592. (Pubitemid 46036592)
8. Leifer, C. A., M. N. Kennedy, A. Mazzoni, C. Lee, M. J. Kruhlak, and D. M. Segal. 2004. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173: 1179-1183. (Pubitemid 38924294)
9. Chockalingam, A., J. L. Cameron, J. C. Brooks, and C. A. Leifer. 2011. Negative regulation of signaling by a soluble form of toll-like receptor 9. Eur. J. Immunol. 41: 2176-2184.
10. Ewald, S. E., B. L. Lee, L. Lau, K. E. Wickliffe, G. P. Shi, H. A. Chapman, and G. M. Barton. 2008. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456: 658-662.
11. Park, B., M. M. Brinkmann, E. Spooner, C. C. Lee, Y. M. Kim, and H. L. Ploegh. 2008. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 9: 1407-1414.
12. Yanai, H., T. Ban, Z. Wang, M. K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, R. Koshiba, et al. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
13. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H. Wang, B. Su, F. O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569. (Pubitemid 47525141)
14. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607. (Pubitemid 34406754)
15. Hurtado, P., and C. A. Peh. 2010. LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells. J. Immunol. 184: 1425-1435.
16. Ganguly, D., G. Chamilos, R. Lande, J. Gregorio, S. Meller, V. Facchinetti, B. Homey, F. J. Barrat, T. Zal, and M. Gilliet. 2009. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206: 1983-1994.
17. Gustafsson, A., S. Sigel, and L. Ljunggren. 2010. The antimicrobial peptide LL37 and its truncated derivatives potentiates proinflammatory cytokine induction by lipoteichoic acid in whole blood. Scand. J. Clin. Lab. Invest. 70: 512-518.
18. Kandler, K., R. Shaykhiev, P. Kleemann, F. Klescz, M. Lohoff, C. Vogelmeier, and R. Bals. 2006. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int. Immunol. 18: 1729-1736. (Pubitemid 44884035)
19. Nagaoka, I., S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, H. Tamura, and D. Heumann. 2001. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-a by blocking the binding of LPS to CD14+ cells. J. Immunol. 167: 3329-3338. (Pubitemid 32852575)
20. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCT) method. Methods 25: 402-408. (Pubitemid 34164012)
21. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407-2412.
22. Wang, Y., L. Liu, D. R. Davies, and D. M. Segal. 2010. Dimerization of Toll-like receptor 3 (TLR3) is required for ligand binding. J. Biol. Chem. 285: 36836-36841.
23. Kawai, T., and S. Akira. 2007. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13: 460-469.
24. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997.The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252. (Pubitemid 27456391)
25. Tamassia, N., V. Le Moigne, M. Rossato, M. Donini, S. McCartney, F. Calzetti, M. Colonna, F. Bazzoni, and M. A. Cassatella. 2008. Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J. Immunol. 181: 6563-6573.
26. Reimer, T., M. Brcic, M. Schweizer, and T. W. Jungi. 2008. Poly(I:C) and LPS induce distinct IRF3 and NF-κB signaling during type-I IFN and TNF responses in human macrophages. J. Leukoc. Biol. 83: 1249-1257. (Pubitemid 351960357)
27. De Miranda, J., K. Yaddanapudi, M. Hornig, and W. I. Lipkin. 2009. Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5. FASEB J. 23: 1064-1071.
28. Town, T., D. Jeng, L. Alexopoulou, J. Tan, and R. A. Flavell. 2006. Microglia recognize double-stranded RNA via TLR3. J. Immunol. 176: 3804-3812. (Pubitemid 43364029)
29. Matsumoto, M., K. Funami, M. Tanabe, H. Oshiumi, M. Shingai, Y. Seto, A. Yamamoto, and T. Seya. 2003. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171: 3154-3162. (Pubitemid 37093540)
30. Marshak-Rothstein, A. 2006. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6: 823-835. (Pubitemid 44631651)
31. Lande, R., D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad, J. Gregorio, S. Meller, G. Chamilos, R. Sebasigari, V. Riccieri, et al. 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra19.
32. Nicodemus, C. F., and J. S. Berek. 2010. TLR3 agonists as immunotherapeutic agents. Immunotherapy 2: 137-140.
33. Hendrix, C. W., J. B. Margolick, B. G. Petty, R. B. Markham, L. Nerhood, H. Farzadegan, P. O. Ts'o, and P. S. Lietman. 1993. Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers. Antimicrob. Agents Chemother. 37: 429-435. (Pubitemid 23072584)
34. Thompson, K. A., D. R. Strayer, P. D. Salvato, C. E. Thompson, N. Klimas, A. Molavi, A. K. Hamill, Z. Zheng, D. Ventura, and W. A. Carter. 1996. Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. 15: 580-587.
35. Itoh, K., A. Watanabe, K. Funami, T. Seya, and M. Matsumoto. 2008. The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-β production. J. Immunol. 181: 5522-5529.
36. Lee, H. K., S. Dunzendorfer, K. Soldau, and P. S. Tobias. 2006. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24: 153-163. (Pubitemid 43214585)
37. Limmon, G. V., M. Arredouani, K. L. McCann, R. A. Corn Minor, L. Kobzik, and F. Imani. 2008. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J. 22: 159-167.
38. Gursel, M., I. Gursel, H. S. Mostowski, and D. M. Klinman. 2006. CXCL16 influences the nature and specificity of CpG-induced immune activation. J. Immunol. 177: 1575-1580. (Pubitemid 44092492)
39. Józefowski, S., T. H. Sulahian, M. Arredouani, and L. Kobzik. 2006. Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides. J. Leukoc. Biol. 80: 870-879. (Pubitemid 44835905)
40. Leonard, J. N., R. Ghirlando, J. Askins, J. K. Bell, D. H. Margulies, D. R. Davies, and D. M. Segal. 2008. The TLR3 signaling complex forms by cooperative receptor dimerization. Proc. Natl. Acad. Sci. USA 105: 258-263.